Kelly Schick C4 Therapeutics, Inc. (CCCC) insider trading activity
Kelly Schick is Chief People Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 52,251 shares of CCCC, which is worth approximately $304,623. The most recent transaction as insider was on Feb 14, 2024, when has been sold 27,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
52.3K
0%
3M change
95.8%
12M change
Total Value Held
$304,623
Kelly Schick Transaction History
Also insider at
KS
Kelly Schick
Chief People Officer
Waltham, MA